person · Reporting owner
Ramchandani Rashmi Virendra
Disclosed activity across 1 company
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| BIOMARIN PHARMACEUTICAL INCBMRN · Entity 2404 | VP, Chief Accounting Officer | January 20, 2026 | January 22, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
BIOMARIN PHARMACEUTICAL INC
Report date January 20, 2026 · Filed January 22, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 25,610 |
Ending reported balance
After 2026-01-20 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-01-20 · Grant · Acquired 18,540 · Balance 18,540 F1: Restricted stock units granted on January 20, 2026. Price not applicable. Row 2 · 2026-01-20 · Grant · Acquired 7,070 · Balance 25,610 F1: Restricted stock units granted on January 20, 2026. Price not applicable. |
| Stock Option (Right to Buy Common Stock)SEC Table II · derivative / convertible security · Conversion / exercise price $56.31 · Expires 2036-01-19 | Direct | 18,220 |
Reported balance
After 2026-01-20 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-01-20 · Grant · Acquired 18,220 · Balance 18,220 F2: Option grant vests 12/48th on January 20, 2027 and 1/48th on the 20th day of each month thereafter. |
Filing footnotes · ownership attribution and instrument terms
F1: Restricted stock units granted on January 20, 2026. Price not applicable.
F2: Option grant vests 12/48th on January 20, 2027 and 1/48th on the 20th day of each month thereafter.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 20, 2026 Filed Jan 22, 2026 23:12 UTC | BIOMARIN PHARMACEUTICAL INC BMRN · Entity 2404 | GrantStock Option (Right to Buy Common Stock) · Derivative | 18,220 | $0.00 Strike: $56.31 | $0.00 |
DisclosureSEC source: 0001628280-26-003139 · wk-form4_1769123524.xml · derivative · entry 3 Ramchandani Rashmi Virendra · CIK 0002106034 · VP, Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,220 Underlying: Common Stock · 18,220 shares Expires 2036-01-19 F2 · derivative.exercise_date: Option grant vests 12/48th on January 20, 2027 and 1/48th on the 20th day of each month thereafter. Read SEC document |
| January 20, 2026 Filed Jan 22, 2026 23:12 UTC | BIOMARIN PHARMACEUTICAL INC BMRN · Entity 2404 | GrantCommon Stock | 7,070 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-003139 · wk-form4_1769123524.xml · nonDerivative · entry 2 Ramchandani Rashmi Virendra · CIK 0002106034 · VP, Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,610 F1 · price: Restricted stock units granted on January 20, 2026. Price not applicable. Read SEC document |
| January 20, 2026 Filed Jan 22, 2026 23:12 UTC | BIOMARIN PHARMACEUTICAL INC BMRN · Entity 2404 | GrantCommon Stock | 18,540 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-003139 · wk-form4_1769123524.xml · nonDerivative · entry 1 Ramchandani Rashmi Virendra · CIK 0002106034 · VP, Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,540 F1 · price: Restricted stock units granted on January 20, 2026. Price not applicable. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.